Trading Isn’t Getting Easier–But Options Just Did!
Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!
>>>

ARWR Insider Trading (Arrowhead Pharmaceuticals)

Insider Ownership Percentage: 3.20%
Insider Buying (Last 12 Months): $43,472.35
Insider Selling (Last 12 Months): $23,631,904.83

Arrowhead Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Arrowhead Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arrowhead Pharmaceuticals Share Price & Price History

Current Price: $35.96
Price Change: Price Increase of +0.75 (2.13%)
As of 07/1/2022 01:00 AM ET

This chart shows the closing price history over time for ARWR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

Arrowhead Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/11/2022Christopher Richard AnzaloneCEOSell146,388$51.91$7,599,001.08View SEC Filing Icon  
1/5/2022Kenneth Allen MyszkowskiCFOSell40,000$61.70$2,468,000.00View SEC Filing Icon  
1/5/2022Patrick C. O'BrienGeneral CounselSell32,500$61.72$2,005,900.00View SEC Filing Icon  
1/4/2022James C HamiltonSVPSell19,375$65.49$1,268,868.75View SEC Filing Icon  
1/3/2022William D. WaddillDirectorSell4,500$64.72$291,240.00View SEC Filing Icon  
12/28/2021Douglas B GivenDirectorBuy655$66.37$43,472.35View SEC Filing Icon  
12/15/2021Christopher Richard AnzaloneCEOSell60,000$67.56$4,053,600.00View SEC Filing Icon  
11/19/2021Javier San MartinInsiderSell19,500$69.31$1,351,545.00View SEC Filing Icon  
10/22/2021Christopher Richard AnzaloneCEOSell50,000$65.63$3,281,500.00View SEC Filing Icon  
10/20/2021Christopher Richard AnzaloneCEOSell15,000$66.23$993,450.00View SEC Filing Icon  
9/13/2021Adeoye Y. OlukotunDirectorSell5,000$63.76$318,800.00View SEC Filing Icon  
6/24/2021Marianne De BackerDirectorSell5,000$89.85$449,250.00View SEC Filing Icon  
6/22/2021Douglass B. GivenDirectorSell4,500$89.21$401,445.00View SEC Filing Icon  
6/22/2021James HassardInsiderSell3,625$89.22$323,422.50View SEC Filing Icon  
2/8/2021Patrick C. O'BrienGeneral CounselSell90,000$88.46$7,961,400.00383,375View SEC Filing Icon  
1/15/2021Douglass B. GivenDirectorSell3,000$83.28$249,840.00View SEC Filing Icon  
1/14/2021James C HamiltonSVPSell10,000$81.29$812,900.00130,064View SEC Filing Icon  
1/12/2021Kenneth Allen MyszkowskiCFOSell13,038$81.02$1,056,338.76445,446View SEC Filing Icon  
1/7/2021James HassardInsiderSell15,625$75.00$1,171,875.00109,375View SEC Filing Icon  
1/6/2021Kenneth Allen MyszkowskiCFOSell30,625$72.44$2,218,475.00486,568View SEC Filing Icon  
1/6/2021Patrick C. O'BrienGeneral CounselSell25,000$72.41$1,810,250.00317,233View SEC Filing Icon  
1/5/2021James C HamiltonSVPSell19,375$72.53$1,405,268.75171,200View SEC Filing Icon  
1/4/2021Douglas B GivenDirectorSell4,000$76.08$304,320.00
12/17/2020Douglass B. GivenDirectorSell9,575$79.32$759,489.00View SEC Filing Icon  
12/10/2020William D. WaddillDirectorSell3,000$71.26$213,780.0026,800View SEC Filing Icon  
12/9/2020Christopher Richard AnzaloneCEOSell38,676$69.06$2,670,964.562,521,561View SEC Filing Icon  
11/19/2020Javier San MartinInsiderSell19,500$69.39$1,353,105.00130,500View SEC Filing Icon  
10/23/2020Christopher Richard AnzaloneCEOSell100,000$58.21$5,821,000.00View SEC Filing Icon  
10/20/2020Kenneth Allen MyszkowskiCFOSell29,166$54.04$1,576,130.64456,834View SEC Filing Icon  
10/9/2020Mauro FerrariDirectorSell10,000$48.00$480,000.0030,971View SEC Filing Icon  
8/13/2020Christopher Richard AnzaloneCEOSell50,000$41.35$2,067,500.002,655,237View SEC Filing Icon  
6/25/2020Christopher Richard AnzaloneCEOSell100,000$38.81$3,881,000.002,605,260View SEC Filing Icon  
6/15/2020Marianne De BackerDirectorBuy500$31.33$15,665.0013,000View SEC Filing Icon  
5/12/2020Michael S PerryDirectorSell36,000$35.83$1,289,880.0014,100View SEC Filing Icon  
4/27/2020Bruce D GivenCOOSell300$40.00$12,000.00851,934View SEC Filing Icon  
4/20/2020Bruce D GivenCOOSell23,515$40.00$940,600.00862,793View SEC Filing Icon  
4/14/2020Douglas B GivenDirectorSell25,000$36.89$922,250.00155,925View SEC Filing Icon  
3/16/2020Marianne De BackerDirectorBuy500$23.94$11,970.0013,000View SEC Filing Icon  
3/11/2020Marianne De BackerDirectorBuy500$28.60$14,300.0013,000View SEC Filing Icon  
2/27/2020Marianne De BackerDirectorBuy500$35.07$17,535.0013,000View SEC Filing Icon  
1/21/2020Kenneth Allen MyszkowskiCFOSell40,313$49.44$1,993,074.72424,536View SEC Filing Icon  
1/13/2020Marianne De BackerDirectorBuy500$54.95$27,475.0013,000View SEC Filing Icon  
1/6/2020Bruce D GivenCOOSell35,613$60.13$2,141,409.69882,759View SEC Filing Icon  
1/6/2020Kenneth Allen MyszkowskiCFOSell20,000$60.11$1,202,200.00403,592View SEC Filing Icon  
1/6/2020Patrick C. O'BrienGeneral CounselSell14,625$60.12$879,255.00267,406View SEC Filing Icon  
12/12/2019Christopher Richard AnzaloneCEOSell100,000$67.50$6,750,000.002,048,684View SEC Filing Icon  
12/2/2019Christopher Richard AnzaloneCEOSell37,967$69.15$2,625,418.052,116,160View SEC Filing Icon  
11/1/2019Kenneth Allen MyszkowskiCFOSell37,884$40.85$1,547,561.40351,420View SEC Filing Icon  
10/10/2019Christopher Richard AnzaloneCEOSell56,325$31.83$1,792,824.752,178,228View SEC Filing Icon  
9/24/2019Christopher Richard AnzaloneCEOSell66,645$28.20$1,879,389.002,146,153View SEC Filing Icon  
9/20/2019Christopher Richard AnzaloneCEOSell4,250$29.00$123,250.002,146,153View SEC Filing Icon  
9/11/2019Michael S PerryDirectorSell85,000$30.00$2,550,000.00121,000View SEC Filing Icon  
9/9/2019Michael S PerryDirectorSell100,000$28.90$2,890,000.00121,000View SEC Filing Icon  
See Full Table
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

64.62% of Arrowhead Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ARWR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arrowhead Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/30/2022Amalgamated Bank71,009$3.27M0.0%-3.7%0.067%Search for SEC Filing on Google Icon
6/7/2022Teachers Retirement System of The State of Kentucky13,600$0.63M0.0%-6.8%0.013%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE826,932$38.03M0.0%+38.8%0.782%Search for SEC Filing on Google Icon
6/2/2022Mirae Asset Global Investments Co. Ltd.149,690$6.88M0.0%-15.4%0.142%Search for SEC Filing on Google Icon
5/27/2022Walleye Capital LLC23,543$1.08M0.0%N/A0.022%Search for SEC Filing on Google Icon
5/23/2022Neuberger Berman Group LLC258,008$11.87M0.0%-5.7%0.244%Search for SEC Filing on Google Icon
5/20/2022The Manufacturers Life Insurance Company 128,481$5.91M0.0%-23.1%0.122%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA53,611$2.47M0.0%+12.0%0.051%Search for SEC Filing on Google Icon
5/17/2022Walleye Capital LLC23,543$1.08M0.0%N/A0.022%Search for SEC Filing on Google Icon
5/17/2022Weiss Multi Strategy Advisers LLC7,011$0.32M0.0%+14.8%0.007%Search for SEC Filing on Google Icon
5/17/2022Cim Investment Management Inc.5,496$0.25M0.1%-60.0%0.005%Search for SEC Filing on Google Icon
5/17/2022Advisors Asset Management Inc.720$33K0.0%+94.6%0.001%Search for SEC Filing on Google Icon
5/17/2022Point72 Hong Kong Ltd2,335$0.11M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/17/2022Quantbot Technologies LP7,701$0.35M0.0%+7,678.8%0.007%Search for SEC Filing on Google Icon
5/17/2022Dynamic Technology Lab Private Ltd6,200$0.29M0.0%N/A0.006%Search for SEC Filing on Google Icon
5/17/2022Eaton Vance Management31,809$1.46M0.0%+316.7%0.030%Search for SEC Filing on Google Icon
5/17/2022Ensign Peak Advisors Inc33,260$1.53M0.0%-3.4%0.031%Search for SEC Filing on Google Icon
5/17/2022Farallon Capital Management LLC142,700$6.56M0.0%-55.5%0.135%Search for SEC Filing on Google Icon
5/17/2022Guggenheim Capital LLC57,036$2.62M0.0%+12.4%0.054%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System128,693$5.92M0.0%-7.4%0.122%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.784,616$36.09M0.0%+23.3%0.744%Search for SEC Filing on Google Icon
5/16/2022PDT Partners LLC16,684$0.77M0.1%+228.0%0.016%Search for SEC Filing on Google Icon
5/16/2022Brinker Capital Investments LLC31,326$1.44M0.0%-14.3%0.030%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP164,587$7.57M0.0%-21.7%0.156%Search for SEC Filing on Google Icon
5/16/2022State Street Corp4,681,955$215.32M0.0%+19.9%4.440%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP23,030$1.06M0.0%+337.8%0.022%Search for SEC Filing on Google Icon
5/16/2022Hood River Capital Management LLC345,085$15.87M0.5%+2.0%0.327%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.2,334,074$107.35M0.0%+1.2%2.213%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG159,326$7.33M0.0%+2.8%0.151%Search for SEC Filing on Google Icon
5/13/2022Ameritas Investment Partners Inc.36,097$1.66M0.1%+1.6%0.034%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC380,300$17.49M0.0%N/A0.361%Search for SEC Filing on Google Icon
5/13/2022Evolutionary Tree Capital Management LLC88,749$4.08M2.8%-23.2%0.084%Search for SEC Filing on Google Icon
5/13/2022Ontario Teachers Pension Plan Board35,601$1.64M0.0%+43.4%0.034%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp1,385,394$63.72M0.0%-2.6%1.314%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.1,085,723$49.93M0.0%+3.4%1.030%Search for SEC Filing on Google Icon
5/13/2022Lazard Asset Management LLC1,927$87K0.0%+37.3%0.002%Search for SEC Filing on Google Icon
5/13/2022First Trust Advisors LP9,561$0.44M0.0%N/A0.009%Search for SEC Filing on Google Icon
5/13/2022Prudential Financial Inc.85,199$3.92M0.0%-49.1%0.081%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.22,906$1.05M0.0%+19.2%0.022%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.228,541$10.51M0.1%-0.2%0.217%Search for SEC Filing on Google Icon
5/13/2022Candriam Luxembourg S.C.A.270,054$12.42M0.1%+356.3%0.256%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.9,718,250$446.94M0.0%+0.8%9.215%Search for SEC Filing on Google Icon
5/13/2022Allianz Asset Management GmbH14,814$0.68M0.0%-64.8%0.014%Search for SEC Filing on Google Icon
5/13/2022Canada Pension Plan Investment Board5,100$0.24M0.0%N/A0.005%Search for SEC Filing on Google Icon
5/13/2022Sei Investments Co.9,534$0.44M0.0%-28.3%0.009%Search for SEC Filing on Google Icon
5/13/2022Vontobel Holding Ltd.6,104$0.28M0.0%-8.6%0.006%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP58,219$2.68M0.0%-52.0%0.055%Search for SEC Filing on Google Icon
5/12/2022Yousif Capital Management LLC56,575$2.60M0.0%+4.4%0.054%Search for SEC Filing on Google Icon
5/12/2022Pensionmark Financial Group LLC30,051$1.38M0.3%+1.2%0.028%Search for SEC Filing on Google Icon
5/12/2022Great West Life Assurance Co. Can57,154$2.70M0.0%+9.4%0.054%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.12,155,084$559.01M0.0%+1.2%11.526%Search for SEC Filing on Google Icon
5/12/2022Commonwealth of Pennsylvania Public School Empls Retrmt SYS38,650$1.78M0.0%+11.8%0.037%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers289,502$13.31M0.0%+2.4%0.275%Search for SEC Filing on Google Icon
5/12/2022Metropolitan Life Insurance Co NY6,357$0.29M0.0%-85.0%0.006%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC120,217$5.53M0.0%+40.9%0.114%Search for SEC Filing on Google Icon
5/12/2022Capital Fund Management S.A.45,544$2.10M0.0%N/A0.043%Search for SEC Filing on Google Icon
5/12/2022Bank of Montreal Can9,290$0.42M0.0%-18.3%0.009%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.6,421$0.30M0.0%N/A0.006%Search for SEC Filing on Google Icon
5/12/2022Eagle Asset Management Inc.535,586$24.63M0.1%+4.2%0.508%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.39,277$1.81M0.0%-60.7%0.037%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.66,474$3.06M0.0%+108.5%0.063%Search for SEC Filing on Google Icon
5/12/2022HighTower Advisors LLC16,988$0.78M0.0%+4.9%0.016%Search for SEC Filing on Google Icon
5/11/2022ACT Capital Management LLC201,000$9.24M9.8%-4.5%0.191%Search for SEC Filing on Google Icon
5/11/2022US Bancorp DE17,418$0.80M0.0%+6.5%0.017%Search for SEC Filing on Google Icon
5/11/2022American Century Companies Inc.5,791$0.27M0.0%-55.4%0.005%Search for SEC Filing on Google Icon
5/11/2022Seven Eight Capital LP7,916$0.36M0.0%N/A0.008%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp1,044,740$48.05M0.0%+0.1%0.991%Search for SEC Filing on Google Icon
5/11/2022Raymond James Financial Services Advisors Inc.65,132$3M0.0%+84.7%0.062%Search for SEC Filing on Google Icon
5/11/2022Handelsbanken Fonder AB17,000$0.78M0.0%-15.4%0.016%Search for SEC Filing on Google Icon
5/11/2022Skandinaviska Enskilda Banken AB publ 6,816$0.31M0.0%-33.2%0.006%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.2,920,953$134.33M0.0%-2.0%2.770%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP11,346$0.52M0.1%N/A0.011%Search for SEC Filing on Google Icon
5/10/2022Sectoral Asset Management Inc.119,700$5.51M1.0%+14.2%0.114%Search for SEC Filing on Google Icon
5/10/2022Profund Advisors LLC20,359$0.94M0.0%-9.2%0.019%Search for SEC Filing on Google Icon
5/10/2022ProShare Advisors LLC40,658$1.87M0.0%-16.8%0.039%Search for SEC Filing on Google Icon
5/10/2022CNA Financial Corp13,590$0.63M0.2%+6.8%0.013%Search for SEC Filing on Google Icon
5/10/2022Mirae Asset Global Investments Co. Ltd.149,690$6.88M0.0%-15.4%0.142%Search for SEC Filing on Google Icon
5/10/2022B. Metzler seel. Sohn & Co. AG10,268$0.47M0.0%N/A0.010%Search for SEC Filing on Google Icon
5/10/2022Privium Fund Management B.V.182,717$8.40M1.9%-10.6%0.173%Search for SEC Filing on Google Icon
5/9/2022Fiera Capital Corp1,137,688$52.32M0.1%-1.3%1.079%Search for SEC Filing on Google Icon
5/9/2022Johnson & Johnson1,260,869$57.99M11.0%-61.3%1.196%Search for SEC Filing on Google Icon
5/9/2022Herold Advisors Inc.1,800$83K0.0%N/A0.002%Search for SEC Filing on Google Icon
5/9/2022Principal Financial Group Inc.379,075$17.43M0.0%-11.4%0.359%Search for SEC Filing on Google Icon
5/9/2022Scotia Capital Inc.6,849$0.32M0.0%+25.7%0.006%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank234,800$10.80M0.0%+7.7%0.223%Search for SEC Filing on Google Icon
5/9/2022Duality Advisers LP12,251$0.56M0.1%N/A0.012%Search for SEC Filing on Google Icon
5/9/2022Beaumont Financial Partners LLC10,450$0.48M0.0%+3.9%0.010%Search for SEC Filing on Google Icon
5/9/2022Teacher Retirement System of Texas20,691$0.95M0.0%+9.1%0.020%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd11,526$0.53M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/6/2022Los Angeles Capital Management LLC8,847$0.41M0.0%+4.7%0.008%Search for SEC Filing on Google Icon
5/6/2022WCM Investment Management LLC139,107$6.40M0.0%+6.8%0.132%Search for SEC Filing on Google Icon
5/6/2022State Board of Administration of Florida Retirement System35,613$1.64M0.0%-7.1%0.034%Search for SEC Filing on Google Icon
5/6/2022Texas Permanent School Fund74,766$3.44M0.0%-0.5%0.071%Search for SEC Filing on Google Icon
5/6/2022KBC Group NV2,192$0.10M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/5/2022Atlantic Private Wealth LLC7,600$0.35M0.3%+15.2%0.007%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund348,422$16.02M0.0%-0.2%0.330%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.248,907$11.45M0.0%+17.5%0.236%Search for SEC Filing on Google Icon
5/4/2022California Public Employees Retirement System204,377$9.40M0.0%-7.2%0.194%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.10,791$1.54M0.0%-48.8%0.010%Search for SEC Filing on Google Icon
5/4/2022State of Michigan Retirement System26,770$1.23M0.0%+1.3%0.025%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in Phase 2b clinical trial to reduce production of angiopoietin-like protein 3; ARO-HSD, which is in Phase 1/2a clinical trial to treat liver diseases; ARO-ENaC, which is in a Phase 1/2a clinical trial to reduce production of the epithelial sodium channel alpha subunit in the airways of the lung; ARO-C3 for the treatment of complement-mediated disease that is in Phase 1/2a clinical trial; ARO-Lung2 for the treatment of chronic obstructive pulmonary disorder; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-XDH to treat uncontrolled gout; ARO-COV for the treatment of COVID-19 and other pulmonary-borne pathogens; and ARO-HIF2, which is in phase 1b clinical trial to treat clear cell renal cell carcinoma. It is also involved in the development of JNJ-3989, a subcutaneously administered RNAi therapeutic candidate to treat chronic hepatitis B virus infection; Olpasiran to reduce the production of apolipoprotein A; and ARO-AMG1 for treating genetically validated cardiovascular targets. Arrowhead Pharmaceuticals, Inc. has a license and research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop ARO-JNJ1, ARO-JNJ2, and ARO-JNJ3 RNAi therapeutics for liver-expressed targets; and license and research collaboration agreement with Takeda Pharmaceuticals U.S.A., Inc. to develop RNAi therapeutic candidate as a treatment for liver disease. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California.
Read More on Arrowhead Pharmaceuticals

Today's Range

Now: $35.96
Low: $34.81
High: $36.65

50 Day Range

MA: $34.55
Low: $27.79
High: $43.91

52 Week Range

Now: $35.96
Low: $26.81
High: $84.83

Volume

731,753 shs

Average Volume

798,056 shs

Market Capitalization

$3.80 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43

Who are the company insiders with the largest holdings of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals' top insider shareholders include:
  1. Christopher Richard Anzalone (CEO)
  2. Kenneth Allen Myszkowski (CFO)
  3. Patrick O'brien (General Counsel)
  4. James C Hamilton (SVP)
  5. Martin Javier San (Insider)
  6. James Hassard (Insider)
  7. Mauro Ferrari (Director)
  8. William D Waddill (Director)
  9. Adeoye Y Olukotun (Director)
  10. Backer Marianne De (Director)
  11. Douglas B Given (Director)
Learn More about top insider investors at Arrowhead Pharmaceuticals.
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.